PRECISION CANCER MEDICINE

DEAD

Serial Number

87624090

Owner

Trovagene, Inc.

Attorney

Brian M. Davis

First Use Date

Apr 30, 2019

Filing Date

Sep 27, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

PRECISION CANCER MEDICINE Trademark

Serial Number: 87624090 • Registration: 5891854

PRECISION CANCER MEDICINE is a trademark filed by Trovagene, Inc. on September 27, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Trovagene, Inc. (34 trademarks)

11055 Flintkote Ave., Suite B
San Diego, CA 92121

Entity Type: 03

Legal Representation

Attorney of Record

Brian M. Davis

2,421 trademarks filed View all →

Correspondence Address

BRIAN M. DAVIS VLP LAW GROUP LLP

5960 FAIRVIEW RD; SUITE 400

CHARLOTTE, NC 28210

UNITED STATES

Trademark Details

Filing Date

September 27, 2017

Registration Date

October 22, 2019

First Use Anywhere

April 30, 2019

First Use in Commerce

April 30, 2019

Published for Opposition

April 17, 2018

Cancellation Date

May 8, 2026

Goods & Services

Research and development of diagnostic assays for the detection of nucleic acids and molecules encoded by nucleic acids; scientific research relating to gene mutations; all of the foregoing for the detection of cancer

Medical testing services, namely, analysis of samples for presence of nucleic acids or molecules encoded by nucleic acids, and diagnosis or detection of medical conditions or infections, namely, cancer

Filing History

CANCELLED SEC. 8 (6-YR)

May 8, 2026 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 22, 2024 REM1

REGISTERED-PRINCIPAL REGISTER

Oct 22, 2019 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 17, 2019 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 14, 2019 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jun 22, 2019 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 22, 2019 AITU

USE AMENDMENT FILED

Jun 12, 2019 IUAF

TEAS STATEMENT OF USE RECEIVED

Jun 12, 2019 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 17, 2018 EXRA

SOU EXTENSION 1 GRANTED

Nov 15, 2018 EX1G

SOU EXTENSION 1 FILED

Nov 15, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 15, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 12, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 17, 2018 NPUB

PUBLISHED FOR OPPOSITION

Apr 17, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 28, 2018 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 10, 2018 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 2, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 2, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 2, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 6, 2018 GNRN

NON-FINAL ACTION E-MAILED

Jan 6, 2018 GNRT

NON-FINAL ACTION WRITTEN

Jan 6, 2018 CNRT

ASSIGNED TO EXAMINER

Jan 4, 2018 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 2, 2017 NWOS

NEW APPLICATION ENTERED

Sep 30, 2017 NWAP

Related Trademarks

More from this Owner

CARDIFF ONCOLOGY

TROVAGENE ONCOLOGY

TROVAGENE

More in Same Class

CMTL CONNECTICUT MATERIALS TESTING LAB,INC.

SWCH